Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis.

Nanna Jordt Kasper Aalbæk Kjærgaard Reimar Wernich Thomsen Signe Borgquist Deirdre P Cronin-Fenton

Published in: Breast cancer research and treatment (2023)

Our findings suggest an elevated risk of T2D in breast cancer survivors, particularly after tamoxifen therapy. Further research is needed to determine the impact of aromatase inhibitors, and chemotherapy on the incidence of T2D after breast cancer.

Keyphrases

risk factors
locally advanced
breast cancer cells
mesenchymal stem cells
positive breast cancer
rectal cancer